Hong Kong Diversified Financial Stock News

JD Health International reported stronger-than-expected third quarter results, partnered with leading pharmaceutical companies, and announced agreements with JD.com involving technology support, supply chain solutions, and healthcare services, with these deals to be voted on at an upcoming general meeting. JD Health’s advances in digital healthcare and ongoing collaborations have reinforced its leadership in online specialty medicines and expanded the reach of its smart health ecosystem...

HBM Holdings (SEHK:2142) has announced a strategic partnership with Evinova China to leverage artificial intelligence and digital technologies in biologics research and development. This move is expected to add momentum to its innovation pipeline and market positioning. See our latest analysis for HBM Holdings. HBM Holdings’ latest surge, up 4% in a single day and 11.6% over the last week, follows the announcement of its AI-driven partnership with Evinova China. This signals that investors...

Lianlian DigiTech (SEHK:2598) has been catching some attention lately, with shares moving in various directions over the past week and month. Investors are weighing recent trading patterns in relation to the company’s overall financial trajectory. See our latest analysis for Lianlian DigiTech. Lianlian DigiTech’s share price has swung lower over the past quarter, with a 90-day share price return of -17.96% and a one-year total shareholder return of -13.4%. While momentum has faded recently,...

Earlier this week, Genscript Biotech Corporation announced that its associate, Legend Biotech Corporation, reported a significant reduction in net losses for the third quarter of 2025, alongside strong sales growth for its CARVYKTI product. This disclosure, released around Genscript’s Analyst/Investor Day, places enhanced focus on the financial ties between the two companies and the implications for Genscript’s broader business outlook. We’ll now explore how Legend Biotech’s improved...

Key Insights The considerable ownership by public companies in Xinte Energy indicates that they collectively have a...

Key Insights China Merchants Port Holdings' significant public companies ownership suggests that the key decisions are...

When close to half the companies in the Entertainment industry in Hong Kong have price-to-sales ratios (or "P/S") below...

There wouldn't be many who think MOG Digitech Holdings Limited's ( HKG:1942 ) price-to-sales (or "P/S") ratio of 0.5x...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Symphony Holdings Limited ( HKG:1223 ) shareholders have seen the share price descend 11% over the month. But that...

Key Insights The considerable ownership by retail investors in Zylox-Tonbridge Medical Technology indicates that they...

China Overseas Land & Investment Limited announced that in October 2025, contracted property sales fell to approximately RMB 18.66 billion, marking a 55.1% decrease year-on-year, with sales area down by 40%. This significant sales slowdown also contributed to a 21.3% year-on-year decline in accumulated contracted sales for the first ten months of 2025, highlighting pressure on the company's property development business. We will explore how the sharp drop in contracted sales shapes China...

East Buy Holding (SEHK:1797) recently made headlines by subscribing to wealth management products from China Guangfa Bank and China Merchants Bank. This move highlights their strategic approach to managing surplus cash. See our latest analysis for East Buy Holding. Momentum has cooled for East Buy Holding, with a 1-month share price return of -12.62% and a steep 3-month decline. This comes even as investor interest in undervalued Asian stocks grows. Still, shareholders have seen a stellar...

Key Insights C&D International Investment Group's significant public companies ownership suggests that the key...

Simcere Pharmaceutical Group (SEHK:2096) has kicked off Phase II clinical trials in China for SIM0278, its IL-2 mutant fusion protein targeting moderate to severe atopic dermatitis. The new study highlights advances in selective immune therapies. See our latest analysis for Simcere Pharmaceutical Group. Momentum has been surging for Simcere Pharmaceutical Group lately, with the stock posting a 1-day share price return of 7.52% and an 18.01% gain over the past month. Its year-to-date share...

TCL Electronics Holdings (SEHK:1070) closed at HK$9.95, maintaining steady momentum over the past month. Investors have observed a gradual climb as the company’s stock gained 7% across the last week, which reflects renewed interest in the consumer electronics sector. See our latest analysis for TCL Electronics Holdings. The recent rally is part of a larger trend, as TCL Electronics’ solid 1-year total shareholder return of 103% and a sharp year-to-date share price gain of almost 60% show that...

As the Asian markets navigate a landscape marked by easing U.S.-China trade tensions and a cautiously optimistic outlook, investors are increasingly on the lookout for opportunities that might be trading below their intrinsic value estimates. In this environment, identifying stocks with strong fundamentals and potential for growth can provide a strategic advantage in building a resilient portfolio.

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Key Insights Insiders appear to have a vested interest in EDA Group Holdings' growth, as seen by their sizeable...

With a price-to-sales (or "P/S") ratio of 0.1x Kingwisoft Technology Group Company Limited ( HKG:8295 ) may be sending...

Key Insights Ever Reach Group (Holdings)'s Annual General Meeting to take place on 20th of November CEO Zhenfeng Wang's...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. On the other hand, if you...

Key Insights Significant control over ANTA Sports Products by private companies implies that the general public has...